Bionobis is positioned on the PRE-ANALYTICAL and ANALYTICAL market by presenting a complete range of MDs (for oropharyngeal / nasopharyngeal samples and saliva collection) as well as IVDDs to efficiently diagnose SARS-CoV-2.